PETTAZZONI, PIERGIORGIO

PETTAZZONI, PIERGIORGIO  

Mostra records
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autore(i) File
4-Hydroxynonenal (HNE), a product of lipide peroxidation, inhibits telomerase activity in Caco-2, a colon cancer cell line, by the inhibition of E-Box activity of the h-TERT promoter 2008 PIZZIMENTI S; BERARDI D; TOALDO C; PETTAZZONI P; DIANZANI MU; MENEGATTI E; BARRERA G
4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity 2010 Pizzimenti S; Menegatti E; Berardi D; Toaldo C; Pettazzoni P; Minelli R; Giglioni B; Cerbone A; Dianzani MU; Ferretti C; Barrera G
Antitumor activity of nanosponge-encapsulated camptotechin in human prostate tumors. 2010 Rosalba Minelli; Roberta Cavalli; Roberto Fantozzi; Chiara Dianzani; Piergiorgio Pettazzoni ; Roberto Pili
Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors 2011 Minelli R; Cavalli R; Fantozzi R; Dianzani C; Pettazzoni P; Ellis L; Shen L; Pili R
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. 2012 Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells 2010 Barrera G; Cerbone A; Toaldo C; Pizzimenti S; Pettazzoni P; Dianzani C; Minelli R; Roma G; Dianzani MU; Ferretti C
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 2011 Minelli, R; Zara, Gp; Serpe, L; Barrera, G; Pettazzoni, P; Fantozzi, R; Dianzani, C.
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. 2012 Minelli R; Serpe L; Pettazzoni P; Minero V; Barrera G; Gigliotti C; Mesturini R; Rosa A; Gasco P; Vivenza N; Muntoni E; Fantozzi R; Dianzani U; Zara G; Dianzani C.
Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell. 2010 Pettazzoni P; Pizzimenti S; Toaldo C; Ciamporcero E; Dianzani MU; Sotomayor P; Tagliavacca L; Pil R; Barrera G.
Combined antitumoral efficacy of the histone deacetilase inhibitor LBH589 and the lipid peroxidation end product 4-hydroxynonenal (HNE) on PC3 prostate cancer cell. 2010 PETTAZZONI P.; PIZZIMENTI S.; TOALDO C.; DIANZANI M.U.; SOTOMAYOR P.; TAGLIAVACCA L.; PILI R.; BARRERA G.
Drug Delivery Nanoparticles in Skin Cancers 2014 Dianzani C; Zara GP; Maina G; Pettazzoni P; Pizzimenti S; Rossi F; Gigliotti CL; Ciamporcero ES; Daga M; Barrera G
Effetti del 4-idrossinonenale, un’aldeide prodotta dalla perossidazione lipidica, sull’espressione dei microRNA in cellule leucemiche umane HL-60 2008 PIZZIMENTI S.; FERRACIN M.; SABBIONI S.; TOALDO C.; PETTAZZONI P.; DIANZANI M.U.; NEGRINI M.; BARRERA G.
Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity 2009 Gentile F; Pizzimenti S; Arcaro A; Pettazzoni P; Minelli R; D'Angelo D; Mamone G; Ferranti P; Toaldo C; Cetrangolo G; Formisano S; Dianzani MU; Uchida K; Dianzani C; Barrera G.
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 2016 Daga, Martina; Ullio, Chiara; Argenziano, Monica; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Ferretti, Carlo; Zara, Gian Paolo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Pettazzoni, Piergiorgio; Corti, Denise; Pizzimenti, Stefania; Barrera, Giuseppina
Identification of 4-Hydroxynonenal-alpha-enolase adducts in HL-60 human leukemic cells: inhibition of plasminogen binding 2008 GENTILE F; PIZZIMENTI S; ARCARO A; PETTAZZONI P; D’ANGELO D; MAMONE G; FERRANTI P; TOALDO C; CENTRANGOLO GP; FORMISANO S; DIANZANI MU; UCHIDA K; BARRERA G
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 2015 Pizzimenti, Stefania; Daga, Martina; Ciamporcero, Eric; Toaldo, Cristina; Pettazzoni, Piergiorgio; Osella-Abate, Simona; Novelli, Mauro; Minelli, Rosalba; Bisazza, Agnese; Gamba, Paola; Testa, Gabriella; Ullio, Chiara; Ferruti, Paolo; Ranucci, Elisabetta; Bernengo, Maria Grazia; Ferretti, Carlo; Dianzani, Chiara; Biasi, Fiorella; Barrera, Giuseppina; Cavalli, Roberta
Increase of telomerase activity and hTERT expression in myelodysplastic syndromes 2009 Briatore F; Barrera G; Pizzimenti S; Toaldo C; Della Casa CD; Laurora S; Pettazzoni P; Dianzani MU; Ferrero D
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. 2011 Pettazzoni P; Pizzimenti S; Toaldo C; Sotomayor P; Tagliavacca L; Liu S; Wang D; Minelli R; Ellis L; Atadja P; Ciamporcero E; Dianzani MU; Barrera G; Pili R.
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 2013 Pizzimenti S; Ciamporcero E; Daga M; Pettazzoni P; Arcaro A; Cetrangolo G; Minelli R; Dianzani C; Lepore A; Gentile F; Barrera G.
Lipid peroxidation in colorectal carcinogenesis: bad and good news 2012 PIZZIMENTI S; TOALDO C; PETTAZZONI P; CIAMPORCERO E; DIANZANI MU; BARRERA G